Cargando…
The Role of Monoclonal Antibodies in the Era of Bi-Specifics Antibodies and CAR T Cell Therapy in Multiple Myeloma
SIMPLE SUMMARY: The introduction of monoclonal antibodies (moAbs) has dramatically improved outcomes in multiple myeloma (MM). Their high clinical efficacy and safe adverse risk profile have made moAbs a first choice in relapsed MM and have led to the introduction of moAbs into the standard upfront...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507719/ https://www.ncbi.nlm.nih.gov/pubmed/34638393 http://dx.doi.org/10.3390/cancers13194909 |